Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease

Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease This retrospective case series study examines immune response of adults with hematologic malignant disease who were vaccinated with 1 of 3 FDA-authorized COVID-19 vaccines between February and April of 2021. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease

Loading next page...
 
/lp/american-medical-association/antibody-response-to-covid-19-vaccination-in-adults-with-hematologic-8r03OVs7Nk

References (13)

  • K. Stephenson, Mathieu Gars, J. Sadoff, A. Groot, Dirk Heerwegh, C. Truyers, C. Atyeo, C. Loos, A. Chandrashekar, K. McMahan, L. Tostanoski, Jingyou Yu, M. Gebre, C. Jacob-Dolan, Zhenfeng Li, S. Patel, L. Peter, Jinyan Liu, E. Borducchi, Joseph Nkolola, Morgana Souza, C. Tan, Rebecca Zash, B. Julg, R. Nathavitharana, R. Shapiro, Ahmed Azim, C. Alonso, K. Jaegle, J. Ansel, Diane Kanjilal, Caitlin Guiney, C. Bradshaw, Anna Tyler, Tatenda Makoni, Katherine Yanosick, M. Seaman, D. Lauffenburger, G. Alter, F. Struyf, M. Douoguih, J. Hoof, H. Schuitemaker, D. Barouch (2021)

    Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.

    JAMA

  • Polack (2020)

    2603

    N Engl J Med, 383

  • L. Baden, H. Sahly, B. Essink, K. Kotloff, S. Frey, R. Novak, D. Diemert, S. Spector, N. Rouphael, C. Creech, J. Mcgettigan, Shishir Kehtan, N. Segall, Joel Solis, A. Brosz, C. Fierro, H. Schwartz, K. Neuzil, L. Corey, P. Gilbert, H. Janes, D. Follmann, M. Marovich, J. Mascola, L. Polakowski, J. Ledgerwood, B. Graham, H. Bennett, R. Pajon, C. Knightly, B. Leav, W. Deng, Honghong Zhou, Shu Han, M. Ivarsson, Jacqueline Miller, T. Zaks (2020)

    Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

    The New England Journal of Medicine

  • Kimberly Paiva, Ricky Grisson, P. Chan, J. Lonks, Ewa King, R. Huard, Diane Pytel-Parenteau, Ga Nam, E. Yakirevich, Shaolei Lu (2020)

    Validation and Performance Comparison of Three SARS-CoV-2 Antibody Assays

    bioRxiv

  • Ribas (2021)

    233

    Cancer Discov, 11

  • F. Polack, Stephen Thomas, N. Kitchin, J. Absalon, A. Gurtman, S. Lockhart, John Perez, Gonzalo Marc, E. Moreira, C. Zerbini, R. Bailey, K. Swanson, Satrajit Roychoudhury, K. Koury, Ping Li, W. Kalina, D. Cooper, R. Frenck, L. Hammitt, Ö. Türeci, H. Nell, A. Schaefer, S. Ünal, D. Tresnan, S. Mather, P. Dormitzer, U. Şahin, K. Jansen, W. Gruber (2020)

    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

    The New England Journal of Medicine

  • Baden (2021)

    403

    N Engl J Med, 384

  • Paiva (2021)

    916

    J Med Virol, 93

  • A. Ribas, Rajarshi Sengupta, T. Locke, S. Zaidi, Katie Campbell, J. Carethers, E. Jaffee, E. Wherry, J. Soria, D039, Gypsyamber Souza (2020)

    Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited.

    Cancer discovery

  • E. Walsh, R. Frenck, A. Falsey, N. Kitchin, J. Absalon, A. Gurtman, S. Lockhart, K. Neuzil, M. Mulligan, R. Bailey, K. Swanson, Ping Li, K. Koury, W. Kalina, D. Cooper, Camila Fontes-Garfias, P. Shi, Ö. Türeci, Kristin Tompkins, K. Lyke, V. Raabe, P. Dormitzer, K. Jansen, U. Şahin, W. Gruber (2020)

    Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

    The New England Journal of Medicine

  • Stephenson (2021)

    1535

    JAMA, 325

  • Walsh (2020)

    2439

    N Engl J Med, 383

  • KJ Paiva, RD Grisson, PA Chan (2021)

    Validation and performance comparison of three SARS-CoV-2 antibody assays

    J Med Virol, 93

Publisher
American Medical Association
Copyright
Copyright 2021 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2021.4381
Publisher site
See Article on Publisher Site

Abstract

This retrospective case series study examines immune response of adults with hematologic malignant disease who were vaccinated with 1 of 3 FDA-authorized COVID-19 vaccines between February and April of 2021.

Journal

JAMA OncologyAmerican Medical Association

Published: Nov 11, 2021

There are no references for this article.